US 11266661
Vaginal inserted estradiol pharmaceutical compositions and methods
granted A61KA61K31/565A61K47/12
Quick answer
US patent 11266661 (Vaginal inserted estradiol pharmaceutical compositions and methods) held by Compass Therapeutics LLC expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/565, A61K47/12, A61K47/14, A61K9/0034